About Diamantis Xylas
Diamantis Xylas is a director at Superluminal Medicines.
Diamantis Xylas first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Diamantis Xylas in the role, so the role may have started earlier or lasted longer.
Superluminal Medicines, Inc.
Director
2024 – 2026 · Boston, MA
Develops small-molecule medicines for people with obesity and cardiometabolic diseases.
Key Colleagues at Startups
The people Diamantis Xylas works with at each company, as listed on that company's latest Form D.
Superluminal Medicines, Inc. · Form D, Sep 3, 2026
HP
Harsha Paladugu
Director
DM
Dylan Morris
Managing Director at Insight Partners
CC
Cony D'cruz
Co-Founder & CEO, director
NS
Nandita Shangari
Director